Replimune Group
REPL
REPL
112 hedge funds and large institutions have $1.32B invested in Replimune Group in 2020 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 45 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
112
Holders Change
+34
Holders Change %
+43.59%
% of All Funds
1.99%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
44
Increased
45
Reduced
16
Closed
10
Calls
–
Puts
$2.33M
Net Calls
-$2.33M
Net Calls Change
-$2.33M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$83.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$65.1M |
| 3 |
State Street
Boston,
Massachusetts
|
+$48.1M |
| 4 |
CA
Corriente Advisors
Fort Worth,
Texas
|
+$27.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$27.2M |
Top Sellers
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$48.9M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$38.9M |
| 3 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$10.3M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$8.22M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$7.87M |
